Dr. Kolb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Rockland Road
Wilmington, DE 19803Phone+1 302-651-5567- Is this information wrong?
Summary
- Dr. Edward Anders Kolb is a pediatric hematologist/oncologist in Wilmington, DE and is affiliated with Alfred I. duPont Hospital for Children. He received his medical degree from Sidney Kimmel Medical College and has been in practice 20 years. He is experienced in primary immunodeficiency diseases, lymphoid leukemia, chronic myelogenous leukemia, graft-versus-host disease, and pharmacology.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1999 - 2002
- Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 1996 - 1999
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1996
- University of PennsylvaniaBA, Biological Basis of Behavior, 1988 - 1992
Certifications & Licensure
- DE State Medical License 2007 - 2025
- PA State Medical License 2015 - 2024
- FL State Medical License 2015 - 2023
- NJ State Medical License 2015 - 2017
- NY State Medical License 1999 - 2009
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Top Doctors Philadelphia Magazine, 2016
- Researcher of the Year Nemours/Alfred I duPont Hospital for Children, 2015
- Top Doctors Delaware Today, 2014
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsIntegrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.Benjamin J Huang, Jenny L Smith, Jason E Farrar, Yi-Cheng Wang, Masayuki Umeda
Nature Communications. 2022-09-19 - 5 citationsLong Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia.Jason E Farrar, Jenny L Smith, Megan Othus, Benjamin J Huang, Yi-Cheng Wang
Journal of Clinical Oncology. 2023-06-01 - 43 citationsGemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AA...Jessica A. Pollard, Erin M. Guest, Todd A. Alonzo, Robert B. Gerbing, Mike R Loken
Journal of Clinical Oncology. 2021-05-28
Journal Articles
- Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse AnalysisMurphy B, Yin H, Maris JM, Kolb EA, Gorlick R, Reynolds CP, Kang MH, Keir ST, Kurmasheva RT, Dvorchik I, Wu J, Billups CA, Boateng N, Smith MA, Lock RB, Houghton PJ, Cancer Res, 1/1/2016
- Initial Testing (Stage 1) of Eribulin, a Novel Tubulin Binding Agent, by the Pediatric Preclinical Testing ProgramKolb EA, Gorlick R, Reynolds CP, Kang MH, Carol H, Lock R, Keir ST, Maris JM, Billups CA, Desjardins C, Kurmasheva RT, Houghton PJ, Smith MA, Pediatr Blood Cancer, 1/1/2013
- Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing programHoughton PJ, Gorlick R, Kolb EA, Lock R, Carol H, Morton CL, Keir ST, Reynolds CP, Kang MH, Phelps D, Maris JM, Billups C, Smith MA, Pediatr Blood Cancer, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Sorafenib in Combination with Standard Chemotherapy for Children with High Allelic Ratio FLT3/ITD+ AML Improves Event-Free Survival and Reduces Relapse Risk: A Report ...Anders E. Kolb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase 1/2 Study of Quizartinib (Q) in Combination with Re-Induction Chemotherapy and As Single-Agent Continuation Therapy in Pediatric and Young Adult Patients with ...Edward Anders Kolb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Transcriptome Profiling of Glycosylation Genes Defines Correlation with E-Selectin Ligand Expression and Clinical Outcome in AMLE. Anders Kolb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Career-Development Lunch Sessions: Pediatric Clinical Malignant Hematology/BMT60th American Society of Hematology Annual Meeting - 12/1/2018
- Immunotherapeutic Targeting of Mesothelin in Acute Myeloid Leukemia in Vitro with Anetumab Ravtansine and a Novel Antibody-Drug Conjugate2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Enhancement of Eligibility Guidelines for Gemtuzumab Ozogamicin Therapy for Childhood Acute Myeloid Leukemia: A Report from Children's Oncology Group Protocol AAML05312018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Other
- Hematopoietic Stem Cell TransplantationPowell JL, Hingorani P, Grupp SA, Kolb EA, eMedicine from WebMD
http://emedicine.medscape.com/article/991032-overview
1/11/2009 - Familial Mosaic Monosomy 7 SyndromeMorrissette JJD, de Chadarevian JP, Kolb EA, GeneReviews
http://www.ncbi.nlm.nih.gov/books/NBK45015/
University of Washington, Seattle - 1/8./2010
Professional Memberships
- Member
- Member
Hospital Affiliations
- Nemours Children’s Hospital, DelawareWilmington, Delaware
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: